Superoxide-induced Type I collagen secretion depends on prolyl 4-hydroxylases.
Aminoquinolines
/ pharmacology
Animals
Aorta
/ cytology
Collagen Type I
/ genetics
Embryo, Mammalian
/ cytology
Fibroblasts
/ drug effects
Glycosylation
Hydroxylation
Mice
Myocytes, Smooth Muscle
/ drug effects
Peptides
/ metabolism
Proline
/ metabolism
Prolyl Hydroxylases
/ metabolism
Superoxides
/ metabolism
Transcription, Genetic
/ drug effects
Prolyl 4-hydroxylases
Reactive oxygen species (ROS)
Superoxide
Type I collagen
Journal
Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516
Informations de publication
Date de publication:
03 09 2020
03 09 2020
Historique:
received:
26
06
2020
accepted:
01
07
2020
entrez:
22
8
2020
pubmed:
21
8
2020
medline:
12
2
2021
Statut:
ppublish
Résumé
Reactive oxygen species (ROS) including superoxide (O
Identifiants
pubmed: 32819558
pii: S0006-291X(20)31379-6
doi: 10.1016/j.bbrc.2020.07.002
pmc: PMC7442856
mid: NIHMS1617903
pii:
doi:
Substances chimiques
Aminoquinolines
0
Collagen Type I
0
Peptides
0
Superoxides
11062-77-4
6-anilino-5,8-quinolinedione
91300-60-6
Proline
9DLQ4CIU6V
Prolyl Hydroxylases
EC 1.14.11.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1011-1017Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL041178
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL064357
Pays : United States
Organisme : NHLBI NIH HHS
ID : R56 HL064357
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no conflicts of interest with the contents of this article.
Références
Exp Mol Pathol. 1983 Dec;39(3):317-26
pubmed: 6196228
Hepatology. 1987 May-Jun;7(3):502-7
pubmed: 3032759
J Hypertens. 2006 Apr;24(4):757-66
pubmed: 16531806
Hypertension. 1998 Sep;32(3):488-95
pubmed: 9740615
Comp Biochem Physiol C Toxicol Pharmacol. 2004 Oct;139(1-3):119-26
pubmed: 15556073
J Clin Invest. 1993 Jan;91(1):46-52
pubmed: 8380815
Cell Mol Biol. 1991;37(7):751-5
pubmed: 1663836
Biochem Biophys Res Commun. 1979 Jul 12;89(1):71-6
pubmed: 224877
Cancer Chemother Pharmacol. 1995;36(4):341-4
pubmed: 7628054
J Vasc Surg. 2006 Feb;43(2):364-71
pubmed: 16476616
Stroke. 1993 Mar;24(3):427-34
pubmed: 8095358
Biochem J. 1991 Apr 1;275 ( Pt 1):241-5
pubmed: 1850240
Circ Res. 1995 Jul;77(1):29-36
pubmed: 7540516
Hepatology. 1997 Feb;25(2):361-7
pubmed: 9021948
J Hepatol. 2013 Mar;58(3):522-8
pubmed: 23178710
Am J Physiol. 1994 Jun;266(6 Pt 2):H2568-72
pubmed: 8024019
Circulation. 1998 Nov 3;98(18):1905-11
pubmed: 9799212
J Cell Biochem. 2003 May 15;89(2):311-20
pubmed: 12704794
Am J Pathol. 2015 May;185(5):1372-84
pubmed: 25759268
J Clin Invest. 1996 Apr 15;97(8):1916-23
pubmed: 8621776
Cell Mol Life Sci. 2019 Sep;76(17):3449-3464
pubmed: 30919021
J Biol Chem. 1996 Sep 20;271(38):23317-21
pubmed: 8798532
Am J Physiol Heart Circ Physiol. 2004 Sep;287(3):H1200-6
pubmed: 15142849
Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8745-9
pubmed: 8710942
Hepatology. 1999 Oct;30(4):987-96
pubmed: 10498651
Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9220-5
pubmed: 9689061
Circ Res. 1999 Oct 15;85(8):753-66
pubmed: 10521248
J Cell Biochem. 2006 Jan 1;97(1):188-97
pubmed: 16173077
Hypertension. 2004 Nov;44(5):655-61
pubmed: 15466667
Arch Dermatol Res. 1993;285(6):352-5
pubmed: 8215584
Circ Res. 1998 Jun 29;82(12):1298-305
pubmed: 9648726
Biochem Biophys Res Commun. 2016 Apr 8;472(3):516-22
pubmed: 26966067
Circ Res. 1994 Jun;74(6):1141-8
pubmed: 8187280
Biochem J. 1989 Oct 15;263(2):539-45
pubmed: 2556998